Results 141 to 150 of about 38,995 (207)
Advent of NK3R Antagonists for the Treatment of Menopausal Hot Flushes: A Narrative Review
ABSTRACT The menopause transition is marked by symptoms predominantly attributed to declining oestrogen levels. Approximately 80% of women experience associated symptoms, and 25% experience severe symptoms. The commonest are vasomotor symptoms (VMS), collectively referring to hot flushes and/or night sweats.
Aaran H. Patel +5 more
wiley +1 more source
Magnetic resonance imaging-targeted prostate biopsy changed everything (so everything has to change). [PDF]
Vickers A.
europepmc +1 more source
What is the ideal number of biopsy cores per lesion in targeted prostate biopsy? [PDF]
Sonmez G +4 more
europepmc +1 more source
A Pilot Study of 18F-DCFPyL PET/CT or PET/MRI and Ultrasound Fusion Targeted Prostate Biopsy for Intra-Prostatic PET-Positive Lesions. [PDF]
Liu Y +7 more
europepmc +1 more source
ABSTRACT Image‐guided thermal ablation (radiofrequency, cryo‐ and microwave ablation) is a safe and effective primary treatment for small renal mass and localised renal cell carcinoma ≤ 4 cm (T1a) with long‐term cancer‐specific survival rates equivalent to surgical resection (Level A).
Matthew Lukies +6 more
wiley +1 more source
Value of systematic sampling in an mp-MRI targeted prostate biopsy strategy. [PDF]
Connor MJ +7 more
europepmc +1 more source
ABSTRACT Background Differentiating transition zone (TZ) prostate cancer (PCa) from benign prostatic hyperplasia (BPH) on multiparametric MRI is challenging. The comparative performance of synthetic MRI (Sy‐MRI) and apparent diffusion coefficient (ADC) for this task is unclear.
Yu Zhang +5 more
wiley +1 more source
The number of involved regions by prostate adenocarcinoma predicts histopathology concordance between radical prostatectomy specimens and MRI/ultrasound-fusion targeted prostate biopsy. [PDF]
Yusim I +6 more
europepmc +1 more source
ABSTRACT Background Klinefelter syndrome (KS) is characterized by marked phenotypic heterogeneity that might be influenced by genetic modifiers, including androgen receptor (AR) repeat length (CAGn and GGCn). The clinical relevance of these repeat lengths in patients with KS before testosterone replacement therapy (TRT) remains unclear.
Andrea Graziani +8 more
wiley +1 more source

